Tuesday February 09 2010 |
Biotechnology feed
|
All feeds
Home
Marketing Services
Antibodies
Careers
Directories
Drugs
Events
Genes
InDepth
News
Reports
Videos
A-Z
Business
Health
Drugs
Sources
Americas
Europe
Asia
Cancer
Cardio-
Diabetes
Bird Flu
Swine Flu
Summaries
Post News
Search
BioNews - BioPortfolio's News Portal
Biotechnology Regulatory Headlines
Sign-up to BioPortfolio's
Biotechnology Regulatory FDA news alerts
.
Subscribe to
BioWatch News Email alerts
-
open
BioWatch PDF brochure
.
Publish your news
using BioNewsCast
- open
BioNewsCast PDF brochure
.
AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation For Duchenne Muscular Dystrophy
Medical News Today:
similar ...
Pharmacodynamics: Scientists at Amgen, Inc. publish research in pharmacodynamics
NewsRX:
similar ...
AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscular Dystro
Pharmacy Choice:
similar ...
AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscular Dystro
PharmaceuticalProcessing:
similar ...
Zeftera problems weigh down Basilea
Pharmafocus:
similar ...
AVI BioPharma, Inc. (AVII)'s Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Mu
BioSpace:
similar ...
AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscular Dystrophy
Freshnews.com:
similar ...
AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscu
Interest!ALERT:
similar ...
AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscular Dystrophy
Street Insider:
similar ...
AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscular Dystro
Yahoo! Canada:
similar ...
AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscular Dystrophy
Stockwatch:
similar ...
AVI BioPharma, Inc. (AVII)'s Drug Candidate AVI-
BioSpace:
similar ...
AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan
Market Wire via MSN Money:
similar ...
AVI BioPharma (AVII) Gets Orphan Drug Designation from EMEA for DMD Treatment AVI-5038
Street Insider:
similar ...
Dendreon: To Short or Not to Short?
Seeking Alpha:
similar ...
Dendreon - To Short or Not to Short
InvestorPlace.com:
similar ...
Basilea reports 2009 financial results
Marketwire via Yahoo!:
similar ...
GSK's TYKERB Receives Accelerated Approval For First-line Combination Treatment Of Hormone Receptor Positive,
Medical News Today:
similar ...
EMEA validates NicOx's naproxcinod marketing authorisation application
PharmaBiz:
similar ...
Duke University publishes research in biopharmaceuticals
Pharmacy Choice:
similar ...
